Leike Zhang

20.1k total citations · 1 hit paper
71 papers, 2.4k citations indexed

About

Leike Zhang is a scholar working on Infectious Diseases, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Leike Zhang has authored 71 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Infectious Diseases, 23 papers in Molecular Biology and 13 papers in Computational Theory and Mathematics. Recurrent topics in Leike Zhang's work include SARS-CoV-2 and COVID-19 Research (24 papers), Viral Infections and Vectors (18 papers) and Viral Infections and Outbreaks Research (14 papers). Leike Zhang is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (24 papers), Viral Infections and Vectors (18 papers) and Viral Infections and Outbreaks Research (14 papers). Leike Zhang collaborates with scholars based in China, Germany and France. Leike Zhang's co-authors include Gengfu Xiao, Wei Wang, Weijuan Shang, Lin Guo, Shaobo Wang, Qingxing Wang, Gengfu Xiao, Wei Liu, Ke Peng and Shufen Li and has published in prestigious journals such as Nature Communications, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Leike Zhang

68 papers receiving 2.4k citations

Hit Papers

Calcium channel blocker amlodipine besylate therapy is as... 2020 2026 2022 2024 2020 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leike Zhang China 24 1.1k 880 383 381 334 71 2.4k
Gengfu Xiao China 29 2.4k 2.1× 1.2k 1.4× 234 0.6× 369 1.0× 426 1.3× 80 4.0k
Scott D. Pegan United States 26 838 0.7× 835 0.9× 329 0.9× 440 1.2× 195 0.6× 60 2.1k
Rahul Singh India 29 513 0.4× 1.1k 1.3× 755 2.0× 154 0.4× 403 1.2× 79 2.9k
Radim Nencka Czechia 28 936 0.8× 1.1k 1.2× 150 0.4× 316 0.8× 532 1.6× 90 2.4k
Timir Tripathi India 29 582 0.5× 1.5k 1.7× 422 1.1× 172 0.5× 149 0.4× 111 2.6k
Thiago Moreno L. Souza Brazil 29 1.2k 1.0× 833 0.9× 169 0.4× 353 0.9× 288 0.9× 92 3.0k
Andrea Savarino Italy 27 1.5k 1.3× 754 0.9× 152 0.4× 406 1.1× 464 1.4× 79 3.2k
Abdo A. Elfiky Egypt 26 2.1k 1.8× 1.2k 1.3× 1.1k 2.9× 212 0.6× 204 0.6× 100 4.1k
Martijn J. van Hemert Netherlands 27 2.0k 1.7× 1.4k 1.6× 125 0.3× 411 1.1× 847 2.5× 68 4.0k

Countries citing papers authored by Leike Zhang

Since Specialization
Citations

This map shows the geographic impact of Leike Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leike Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leike Zhang more than expected).

Fields of papers citing papers by Leike Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leike Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leike Zhang. The network helps show where Leike Zhang may publish in the future.

Co-authorship network of co-authors of Leike Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Leike Zhang. A scholar is included among the top collaborators of Leike Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leike Zhang. Leike Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Jie, Cheng Yan, Yumin Zhang, et al.. (2024). Design, synthesis, and evaluation of novel oxyacanthine derivatives for anti-SARS-CoV-2 activity. Bioorganic & Medicinal Chemistry Letters. 113. 129951–129951.
2.
Feng, Bo, Yumin Zhang, Xin Liu, et al.. (2024). Discovery and characterization of novel potent non-covalent small molecule inhibitors targeting papain-like protease from SARS-CoV-2. Acta Pharmaceutica Sinica B. 14(7). 3286–3290. 3 indexed citations
3.
Chen, Jiyao, Jingfang Mu, Yuming Zhang, et al.. (2024). Targeting viral suppressor of RNAi confers anti-coronaviral activity. Molecular Therapy. 33(1). 201–214. 1 indexed citations
4.
Bie, Yuanyuan, Jieling Zhang, Jiyao Chen, et al.. (2024). Design of antiviral AGO2-dependent short hairpin RNAs. Virologica Sinica. 39(4). 645–654. 1 indexed citations
5.
Zhang, Ruxue, Qiaoyu Hu, Hui Li, et al.. (2023). Discovery, synthesis and mechanism study of 2,3,5-substituted [1,2,4]-thiadiazoles as covalent inhibitors targeting 3C-Like protease of SARS-CoV-2. European Journal of Medicinal Chemistry. 249. 115129–115129. 11 indexed citations
6.
Yang, Hanxi, Xinyao Chen, Qiumeng Zhang, et al.. (2023). Design, synthesis and biological evaluation of covalent peptidomimetic 3CL protease inhibitors containing nitrile moiety. Bioorganic & Medicinal Chemistry. 87. 117316–117316. 5 indexed citations
7.
Jiang, Xiaming, Qilin Xin, Kai Liu, et al.. (2023). Regulation of the WNT-CTNNB1 signaling pathway by severe fever with thrombocytopenia syndrome virus in a cap-snatching manner. mBio. 14(6). e0168823–e0168823. 3 indexed citations
8.
Zhang, Yumin, Yuan Sun, Weijuan Shang, et al.. (2023). A viral RNA-dependent RNA polymerase inhibitor VV116 broadly inhibits human coronaviruses and has synergistic potency with 3CLpro inhibitor nirmatrelvir. Signal Transduction and Targeted Therapy. 8(1). 360–360. 11 indexed citations
9.
Xia, Bingqing, Xiaoyan Pan, Rong‐Hua Luo, et al.. (2023). Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2. Cell Discovery. 9(1). 2–2. 42 indexed citations
10.
Yang, Hanxi, Yan Zhang, Xiangrui Jiang, et al.. (2023). Design, synthesis and biological evaluation of peptidomimetic benzothiazolyl ketones as 3CLpro inhibitors against SARS-CoV-2. European Journal of Medicinal Chemistry. 257. 115512–115512. 7 indexed citations
11.
Zhang, Leike, Qingxing Wang, Lingyu Zhang, et al.. (2023). CCR2 is a host entry receptor for severe fever with thrombocytopenia syndrome virus. Science Advances. 9(31). 33 indexed citations
12.
Wang, Bo, et al.. (2023). Hsp90 β is critical for the infection of severe fever with thrombocytopenia syndrome virus. Virologica Sinica. 39(1). 113–122. 1 indexed citations
13.
Luan, Xiaodong, Xinming Li, Yufan Li, et al.. (2022). Antiviral drug design based on structural insights into the N-terminal domain and C-terminal domain of the SARS-CoV-2 nucleocapsid protein. Science Bulletin. 67(22). 2327–2335. 17 indexed citations
14.
Wang, Yanbo, Xiaming Jiang, Zheng Fu, et al.. (2021). Decreased inhibition of exosomal miRNAs on SARS-CoV-2 replication underlies poor outcomes in elderly people and diabetic patients. Signal Transduction and Targeted Therapy. 6(1). 300–300. 55 indexed citations
15.
Su, Haixia, Sheng Yao, Wenfeng Zhao, et al.. (2021). Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease. Nature Communications. 12(1). 3623–3623. 142 indexed citations
16.
Amporndanai, Kangsa, Xiaoli Meng, Weijuan Shang, et al.. (2021). Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives. Nature Communications. 12(1). 3061–3061. 178 indexed citations
17.
Wang, Qingxing, Yun Luo, Weijuan Shang, et al.. (2021). Comprehensive interactome analysis of the spike protein of swine acute diarrhea syndrome coronavirus. Biosafety and Health. 3(3). 156–163. 3 indexed citations
18.
Li, Shufen, Hao Li, Yulan Zhang, et al.. (2020). SFTSV Infection Induces BAK/BAX-Dependent Mitochondrial DNA Release to Trigger NLRP3 Inflammasome Activation. Cell Reports. 30(13). 4370–4385.e7. 112 indexed citations
19.
Zhang, Leike, Bo Wang, Qilin Xin, et al.. (2019). Quantitative Proteomic Analysis Reveals Unfolded-Protein Response Involved in Severe Fever with Thrombocytopenia Syndrome Virus Infection. Journal of Virology. 93(10). 27 indexed citations
20.
Wang, Shaobo, Yang Liu, Jiao Guo, et al.. (2017). Screening of FDA-Approved Drugs for Inhibitors of Japanese Encephalitis Virus Infection. Journal of Virology. 91(21). 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026